WST Stock Soars After Company Raises Full-Year Guidance On Strong Demand For GLP-1 Drug Components
Stocktwits·12h ago
More News
Here's Why You Should Add OPKO Health Stock to Your Portfolio
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
Zacks·13h ago
WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit
West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.
Zacks·14h ago
Stock Market Today: Stocks Sink, Oil Surges After U.S. Imposes New Russian Sanctions
This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here.Happy Thursday. This is TheStreet's Stock...
TheStreet.com·19h ago
West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates
West Pharmaceutical (WST) delivered earnings and revenue surprises of +17.37% and +2.43%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20h ago
West Reports Third-Quarter 2025 Results
West Reports Third-Quarter 2025 Results West Reports Third-Quarter 2025 Results PR Newswire EXTON, Pa., Oct. 23, 2025 -Delivered solid growth across Proprietary Products and Contract Manufacturing...
PR Newswire·21h ago
BDX Launches AI-Enabled Platform to Unify Healthcare Connectivity
BD's new AI-driven Incada Platform and upgraded Pyxis Pro system unite connected care, driving its digital healthcare edge.
Zacks·3d ago
Avantor Partners With BlueWhale Bio to Advance CAR-T Manufacturing
AVTR collaborates with BlueWhale Bio to speed CAR-T manufacturing using CDNP tech, aiming to scale production and expand patient access.
Zacks·7d ago
WST Q3 Earnings Preview: Can GLP-1 Momentum Outweigh Margin Pressure?
West Pharma's Q3 numbers hinge on robust GLP-1 and biologics demand, but labor constraints, tariffs, and plant shutdowns could test its margin resilience.
Zacks·7d ago
Reasons to Add HealthEquity Stock to Your Portfolio for Now
HQY's strong Q2, expanding HSAs and AI-driven efficiencies highlight its growth momentum despite data security risks.